Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Explore various ways to monetize your skills and effectively manage your debt. Learn how to turn your expertise into extra income.
19,574 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Is the trump bull market running on fumes, or is a deeper money trail powering this rally? This article tracing flows...
A retiree with a large 401(k) balance faces steep taxation on Social Security under a rule unchanged since 1984. The ...
Seven AI models tackle the 2026 World Cup, but what does that mean for investors in crypto? This story parses predict...
A major insider sale at TransMedics grabbed attention after the stock slumped about 45%. This article dives into what...
As Buffett retires, Greg Abel takes the helm. Yet Berkshire’s quieter stock picker is delivering. This story breaks d...
Bond ETFs face a steady rate backdrop as the fed's benchmark rate 3.5%–3.75% holds. This guide breaks down what it me...
A major hedge-like fund reduced its BlackLine stake, sending the stock lower. This article breaks down the why, what ...
XRP has faced big swings, yet Ripple’s developments could shift the long-term outlook. This guide maps out scenarios ...
Berkshire Hathaway stands at a pivotal crossroads as a new era begins. This article breaks down five-year scenarios, ...
GTS Securities recently sold a large chunk of its XOVR exposure, shedding about 19.46 million shares worth roughly 35...
When AI-assisted reviews uncover a serious flaw in a blockchain project, markets react fast. Anthropic's just found t...